Condition: Choledochal Cyst · Sponsor: Beijing Tsinghua Chang Gung Hospital
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.
This description comes directly from the study's public registry record.
Changzhen Yang, MD · +86 18810915262 · ycz23@mail.tsinghua.edu.cn
Shuo Jin, PhD · +86 18611172714 · jsa01263@btch.edu.cn
Always discuss trial participation with your own doctor first.
| Beijing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07036848